FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells

Area of Science:

• Epigenetics
• Cancer Biology
• Molecular Oncology

Background:

• DNA methylation is a key epigenetic mechanism involved in gene silencing, particularly of tumor suppressor genes in cancer.
• The precise mechanisms regulating DNA methylation patterns in cancer remain incompletely understood.
• Identifying novel regulators of DNA methylation is crucial for understanding cancer development and for therapeutic targeting.

Purpose of the Study:

• To investigate the role of the transcription factor FOXA1 (Forkhead box A1) in regulating gene CpG island methylation.
• To evaluate the potential of FOXA1 as a target for controlling DNA methylation in breast cancer cells.

Main Methods:

• FOXA1 expression was manipulated in MCF-7 breast cancer cells using siRNA (knock-down) and plasmid transfection (over-expression).
• Quantitative methylation-specific PCR (qMSP) and quantitative reverse transcription PCR (qRT-PCR) were used to assess DNA methylation and mRNA levels.
• Cell proliferation and apoptosis were evaluated using MTT assays and flow cytometry.

Main Results:

• Suppression of FOXA1 led to increased methylation and decreased mRNA levels of tumor suppressor genes (DAPK, MGMT, RASSF1A, p53).
• Conversely, over-expression of FOXA1 resulted in decreased methylation and increased mRNA levels of these genes.
• FOXA1 suppression upregulated DNA methyltransferases (DNMT1, DNMT3A, DNMT3B) and promoted cell proliferation while inhibiting apoptosis.

Conclusions:

• FOXA1 appears to modulate the methylation status of tumor suppressor gene promoters, potentially by altering the expression of DNA methyltransferases.
• FOXA1 may serve as a potential therapeutic target for demethylation strategies in the prevention and treatment of breast cancer.